Last update 01 Jul 2024

AntiALPP CART cells (TCRCure Biotech)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
CARsT therapy TCRCure Biotech, Retroviral vector-transduced anti-ALPP CARs-T therapy, TC-A101
Target
ALPP
Mechanism
ALPP inhibitors(alkaline phosphatase, placental inhibitors), Gene transference, T lymphocyte replacements
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication-
Inactive Indication
Endometrial CarcinomaOvarian CancerOvarian Epithelial Carcinoma+ [2]
Originator Organization
Beijing TCR CURE Biopharma Technology Co., LtdBeijing TCR CURE Biopharma Technology Co., Ltd
Active Organization-
Inactive Organization
Beijing TCR CURE Biopharma Technology Co., LtdBeijing TCR CURE Biopharma Technology Co., Ltd
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with AntiALPP CART cells (TCRCure Biotech)
NCT04627740 / Unknown statusPhase 1/2IIT
A Single-Arm, Single-Center, Open-Label Pilot Study of Anti-ALPP CART-cells in Patient With Alkaline Phosphatase, Placental (ALPP)-Positive Metastatic Ovarian and Endometrial Cancer.
100 Clinical Results associated with AntiALPP CART cells (TCRCure Biotech)
Login to view more data
100 Translational Medicine associated with AntiALPP CART cells (TCRCure Biotech)
Login to view more data
100 Patents (Medical) associated with AntiALPP CART cells (TCRCure Biotech)
Login to view more data
100 Deals associated with AntiALPP CART cells (TCRCure Biotech)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endometrial CarcinomaPhase 2-
Beijing TCR CURE Biopharma Technology Co., Ltd
01 Dec 2020
Ovarian CancerPhase 2-
Beijing TCR CURE Biopharma Technology Co., Ltd
01 Dec 2020
Ovarian Epithelial CarcinomaPreclinical
CN
Beijing TCR CURE Biopharma Technology Co., Ltd
30 Dec 2020
Testicular NeoplasmsPreclinical
CN
Beijing TCR CURE Biopharma Technology Co., Ltd
30 Dec 2020
Uterine Cervical CancerPreclinical
CN
Beijing TCR CURE Biopharma Technology Co., Ltd
30 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04627740 (ESMO2022)
ManualManual
Phase 1
Endometrioid carcinoma ovary
ALPP
3
niocseogqw(fmvnkhaxyy) = none wvfbalbuwz (fptxebuhdh )
View more
Positive
10 Sep 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free